Onyx Pharmaceuticals

Onyx Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing innovative therapies for cancer treatment. The company's primary product is Nexavar, an oral multiple kinase inhibitor designed to target proteins that contribute to tumor cell proliferation and angiogenesis. By concentrating on improving the quality of life for cancer patients, Onyx Pharmaceuticals aims to deliver effective treatment options within the competitive landscape of oncology.